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Abstract: Introduction: Survivors of pediatric brain tumors are at significant risk for both 
neurocognitive impairments and psychological adjustment difficulties. However, these 
domains of negative sequelae are primarily examined as distinct sets of symptoms. Thus, 
the current study aimed to evaluate comprehensive profiles of late effects, across both 
neurocognitive and psychosocial domains, experienced by young brain tumor survivors. 
Additionally, several demographic and disease characteristics were evaluated as 
predictors of late effect profiles. Method: Pediatric brain tumor survivors (N=89) who 
were assessed in a neuropsychological clinic between May 2009 and May 2018, were 
diagnosed at least one year prior, and were off-treatment for at least three months, were 
included. Parent- and teacher-report of psychological symptoms (Child Behavior 
Checklist and Teacher Report Form), and performance-based measures of neurocognitive 
functioning (Wechsler Scales, Tower of London-DX-Drexel Version) were examined 
using latent profile analysis and model fit criterion including the bootstrapped likelihood 
ratio difference test and the Bayesian Information Criteria. The R3STEP procedure was 
employed to identify predictors of class membership. Results: Four classes were 
identified: (1) “Average” (n = 47) characterized by average functioning across all 
domains, (2) “Cognitive Deficit” (n = 25) characterized by average psychosocial 
functioning and impaired cognitive functioning, (3) “Social/Cognitive Deficit” (n = 9) 
characterized by elevated social problems and significant neurocognitive impairments, 
and (4) “Discrepant” (n = 8), characterized by impaired visual planning and problem-
solving and elevated parent-reported psychosocial problems, but average processing 
speed, working memory, and teacher-reported psychosocial outcomes. Ethnicity, race, 
treatment with radiation, and the diagnoses of neurofibromatosis 1, hydrocephalus, and 
posterior fossa syndrome, were all significant predictors of class membership (ps < 0.05). 
Conclusion: Findings were consistent with extant literature, while also shedding light on 
patterns of relations among neurocognitive and psychosocial domains among survivors. 
Results show that distinct neuropsychological phenotypes may exist, suggesting the need 
for closer examination of demographic and illness-related factors that appear to 
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Individuals diagnosed with a brain tumor in childhood or adolescence are known to be at 
significant risk for a variety of negative sequelae following oncological treatment. Emergence of 
neuropsychological problems has been documented as early as within the first year after 
diagnosis, and evidence suggests a persistent and steep decline in functioning during the first few 
years off-treatment (Embry et al., 2015; Mulhern, Merchant, Gajjar, Reddick, & Kun, 2004; 
Spiegler, Bouffet, Greenberg, Rutka, & Mabbott, 2004; Turner, Rey-Casserly, Liptak, & Chordas, 
2009). Further, these difficulties appear to be long-lasting, as they relate to reduced independent 
living and quality of life in later adulthood (Gurney et al., 2009; Maurice-Stam, Grootenhuis, 
Caron, & Last, 2007; Zebrack et al., 2004). Thus, parallel to the rise in survival rates of pediatric 
brain tumors, the literature has turned to focus on understanding the long-term outcomes of youth 
treated for brain tumors (Siegel, Miller, & Jemal, 2016). 
Among the most robust findings in the pediatric brain tumor literature is the elevated prevalence 
of neurocognitive deficits (Glass et al., 2017; Mulhern et al., 2004; Turner et al., 2009). In fact, 
compared to healthy siblings and survivors of non-central nervous system malignancies, survivors 
of pediatric brain tumors appear to be at the greatest risk for impairments in global intellectual 
and cognitive functioning (Duffner, 2004; Ellenberg et al., 2009; Prasad et al., 2015; Ullrich & 
Embry, 2012; Winick, 2011). Pediatric brain tumor survivors exhibit reduced white matter 





(Conklin et al., 2013; Hardy, Willard, Gioia, Sharkey, & Walsh, 2018; Hardy, Willard, Wigdor, 
Allen, & Bonner, 2015; Kahalley et al., 2013). Processing speed, working memory, and attentional 
control appear to be some of the most highly impacted subdomains, and a significant subset of 
survivors demonstrate deficits in these processes that are well below the performance of healthy age- 
and gender-matched peers (De Ruiter, Van Mourik, Schouten-Van Meeteren, Grootenhuis, & 
Oosterlaan, 2013; Mulhern et al., 2004; Reddick et al., 2003).  
Declines in general intelligence, potentially driven by underlying difficulties in knowledge 
acquisition, have been observed among brain tumor survivors (Mulhern et al., 2004; Robinson, 
Fraley, Pearson, Kuttesch, & Compas, 2013; Spiegler et al., 2004). Specifically, it has been suggested 
that the mean intelligence quotient (IQ) for pediatric survivors of brain tumors remains well below 
that of normative samples (Turner et al., 2009). Importantly, these negative outcomes have been 
documented by multiple informants, including parents, teachers, and the survivors themselves, as well 
as through performance-based assessments (Hardy et al., 2018; Prasad et al., 2015; Zeltzer et al., 
2009). Thus, an increased understanding of potential factors associated with these neurocognitive 
outcomes is necessary. 
In addition to neurocognitive late effects, survivors of pediatric brain tumors are also at significant 
risk for poor psychological adjustment (Schultz et al., 2007; Turner et al., 2009; Zeltzer et al., 2009). 
Consistent with neurocognitive findings, the literature on psychosocial outcomes indicates that 
individuals treated for pediatric brain tumors are at greater risk for internalizing and behavioral 
difficulties, as compared to healthy peers and survivors of other cancers (Patenaude & Kupst, 2005; 
Schultz et al., 2007; Zebrack et al., 2004; Zeltzer et al., 2009). Although many studies report great 
resilience among survivors, it has been noted that approximately 30% of adult survivors of childhood 
cancers show psychological problems, and that those treated for brain tumors experience considerably 





literature, suggesting that specific psychological sequelae may be dependent on factors such as age, 
symptoms assessed, and informant (Fuemmeler, Elkin, & Mullins, 2002). 
Nevertheless, the extant literature suggests that pediatric brain tumor survivors are indeed at risk for 
elevated global distress and reduced quality of life (Zebrack et al., 2004; Zeltzer et al., 2009). More 
specifically, significant evidence has accrued documenting internalizing symptoms, including 
increased depressive and anxious symptoms, suicidal ideation, emotion dysregulation, and 
somatization, which persist through adulthood (Fuemmeler et al., 2002; Prasad et al., 2015; Recklitis 
et al., 2010; Turner et al., 2009; Zebrack et al., 2004; Zeltzer et al., 2009). Although the research on 
behavioral problems is more limited, elevated risk is also apparent for externalizing problems among 
this population (Fuemmeler et al., 2002; Turner et al., 2009). The literature suggests that behavioral 
problems are prevalent, with both parents and teachers reporting difficulties with aggression, 
antisocial behaviors, and behavioral regulation at home and at school (Hardy et al., 2018; Holmquist 
& Scott, 2002; Schultz et al., 2007). 
Following from these findings regarding adjustment outcomes, more recent literature has identified 
social late effects of pediatric brain tumor treatment (Schulte & Barrera, 2010). For instance, one 
small study suggested that brain tumor survivors experience more social functioning deficits and 
impairments in social-cognitive skills than typically developing children (Willard, Allen, Hardy, & 
Bonner, 2017). Another investigation of adolescents found that survivors reported lower social 
acceptance and reduced self-perception, as compared to adolescents who had just begun oncological 
treatment (Hardy, Willard, Watral, & Bonner, 2010). It may be that brain tumor survivors have 
reduced opportunity for social interactions, resulting in the social isolation, victimization, and 
withdrawal behaviors that have been observed (Salley et al., 2015). Systematic reviews have 
corroborated these findings, establishing that pediatric brain tumor survivors appear to be at risk for 
poorer social competency, by both parent- and teacher-report, and are less socially accepted by peers 





social attainment, including lower rates of marriage and employment, fewer friends, less education, 
and less independent living, rendering it particularly valuable to evaluate social outcomes among this 
population (Gurney et al., 2009; Prasad et al., 2015). 
Importantly, several key predictors of these neurocognitive and psychosocial late effects have been 
identified. Demographic characteristics, such as female sex and lower socioeconomic status, as well 
as disease variables, including tumor location, have been shown to predict greater neurocognitive 
impairments and psychological adjustment difficulties (Fuemmeler et al., 2002; Moore, 2005; 
Zebrack et al., 2004). Younger age at diagnosis and greater time since diagnosis also appear to predict 
greater deficits across domains of functioning (Mulhern et al., 2004; Reimers et al., 2003). Further, 
medical outcomes, including cerebellar mutism (posterior fossa syndrome) and ventriculoperitoneal 
shunt placement due to hydrocephalus, have been linked with worse neurocognitive outcomes 
(Ellenberg et al., 2009; Palmer et al., 2010).  
However, treatment variables appear to be the most robust predictors of IQ decline and 
neurocognitive deficits (Patenaude & Kupst, 2005; Reimers et al., 2003; Turner et al., 2009). The 
presence and dosage of cranial radiation therapy, specifically larger radiation doses and greater 
irradiated brain volume, are well-established risk factors for negative neuropsychological outcomes 
(Kieffer-Renaux et al., 2007; Mulhern et al., 2004). It is important to note that these findings are 
rarely consistent in the literature, as risk factors vary across informants, age groups, and samples 
(Ellenberg et al., 2009; Fuemmeler et al., 2002; Mulhern et al., 2004; Turner et al., 2009). Therefore, 
an interaction likely exists between several disease and demographic characteristics, which may lead, 
in combination, to the development of both neurocognitive and psychosocial sequelae. Collectively, 
these findings argue for a more precise understanding of the risk factors for late effects among 





Interestingly, research regarding the full constellation of late effects experienced by pediatric brain 
tumor survivors is quite limited. Most studies seem to examine sequelae as distinct sets of symptoms, 
such as those concerning neurocognitive impairments (e.g., De Ruiter, Van Mourik, Schouten-Van 
Meeteren, Grootenhuis, & Oosterlaan, 2013), and those investigating psychosocial outcomes (e.g., 
Zebrack et al., 2004). Even those studies that examine multiple domains of functioning appear to do 
so by assessing discrete functions in an independent fashion. For instance, Prasad and colleagues 
(2015) found elevated risk for adolescent and early young adulthood survivors across psychosocial 
and neurocognitive domains, but did not examine the pattern of impairment across those domains. 
Hardy and colleagues (2018) also identified behavioral and neurocognitive difficulties among brain 
tumor survivors with identified attention deficits, yet correlations among these variables were not 
reported. Furthermore, several reviews imply that connections exist, but report findings within the 
context of sections focused on separate domains (Fuemmeler et al., 2002; Turner et al., 2009; Zeltzer 
et al., 2009). Recent evidence has emerged suggesting a direct link between neurocognitive decline 
and social deficits among brain tumor survivors, but these findings are limited (Schulte & Barrera, 
2010; Willard et al., 2017). Among general populations, a strong association between neurocognitive 
impairments and psychosocial distress is supported, yet this link is rarely evaluated among pediatric 
brain tumor survivors, a population at significant risk for impaired functioning in both domains 
(Castaneda, Tuulio-Henriksson, Marttunen, Suvisaari, & Lönnqvist, 2008; Rock, Roiser, Riedel, & 
Blackwell, 2014). 
Thus, the current study aimed to evaluate profiles of neuropsychological late effects experienced by 
young brain tumor survivors. Specifically, the pattern of impairment across multiple neurocognitive 
and psychosocial domains was examined among youth who are survivors of pediatric brain tumors. 
As this study is exploratory in nature, it was hypothesized that unmeasured classes of symptom 
phenotypes would be identified, and would be characterized by distinct profiles of difficulties across 





performance-based measures. However, the specific distinctions among profiles could not be 
anticipated. Additionally, the current study aimed to ascertain if demographic and disease 
characteristics, including sex, age at diagnosis, and hydrocephalus, show reliable predictive utility of 








REVIEW OF LITERATURE 
Epidemiology and Treatment of Pediatric Brain Tumors 
Pediatric brain tumors are the second most common cancer diagnosis of childhood, following 
leukemia, for all individuals aged 19 or below (Siegel, Miller, & Jemal, 2016). They account for 
nearly 26% of all childhood cancers, as well as 20% of cancer diagnoses among older adolescents 
between the ages of 15 and 19 years old. Thus, they represent the most common diagnosis for the 
older adolescent age group (Siegel et al., 2016). Since 1975, the incidence rate of childhood 
cancer has been steadily increasing; meanwhile, mortality rates from pediatric cancers have 
continuously declined (Siegel et al., 2016). Despite this decline in mortality, it is important to 
note that pediatric brain tumors continue to be the leading cause of cancer deaths among both 
children and adolescents. Although any child may experience a brain tumor, it appears that males 
and children who are Caucasian, Asian, or Pacific Islander may be at a greater risk for a brain 
tumor diagnosis (Siegel et al., 2016). However, similar to most cancer-related outcomes, the risk 
for developing a brain tumor varies by tumor type.  
Common Brain Tumor Diagnoses 
A review of the epidemiology of pediatric brain tumors determined that there are more than 100 
histological subtypes of childhood brain tumors (Johnson et al., 2014). The incidence of those 
that are most common in early childhood, including pilocytic astrocytomas, medulloblastomas, 





including germ cell tumors appear to peak in adolescence (Kieran, Walker, Frappaz, & Prados, 
2010). This suggests an interrelationship with brain growth and development, such that the 
occurrence of pediatric brain tumors may be connected to maturation process of children’s 
cerebrum. 
Gliomas, which are tumors that develop in the glial cells, appear to be the most common among 
young children between birth and 14-years-old (Johnson et al., 2014). Gliomas tend to result in 
symptoms including seizures, headaches, and neurologic deficits, due to their primary locations in 
the central nervous system (Johnson et al., 2014). Gliomas are often categorized into three groups 
including astrocytomas, ependymomas, and oligodendrogliomas, which each have further 
subdivisions (Kieran et al., 2010). Pilocytic astrocytomas, one type of astrocytomas, accounts for 
approximately 17% of all childhood brain tumors (Johnson et al., 2014). Other gliomas, such as 
oligodendrogliomas, are more common in adults, whereas ependymomas are more rare among 
both pediatric and adult patients (Kieran et al., 2010). Prognosis also varies greatly across glioma 
diagnoses, with pilocytic astrocytomas having a very high survival rate, and brain stem tumors 
having very poor prognoses (Johnson et al., 2014). 
Embryonal tumors, which appear to develop in the embryonic cells that remain in the brain after 
birth, are the second most common pediatric brain tumor diagnosis (Kieran et al., 2010). 
Embryonal tumors also consist of three main subtypes, including medulloblastomas, primitive 
neuroectodermal tumors (PNET), and atypical teratoid/rhabdoid tumors (ATRT; Kieran et al., 
2010). Medulloblastomas are the most common embryonal tumor and account for more than 20% 
of childhood brain tumors, whereas the diagnosis is quite rare among adults (Kieran et al., 2010). 
The 5-year survivorship rate is approximately 80% for children with standard-risk 
medulloblastomas, but prognosis differs significantly by tumor subtype (Johnson et al., 2014; 
Kieran et al., 2010). PNET are tumors of the supratentorial region of the brain, or the cerebrum, 





2010). Lastly, ATRT is the most rare embryonal tumor diagnosis, and typically occurs among 
children younger than three years old (Johnson et al., 2014). Prognosis appears to be significantly 
related to age, with greater age linked with better outcomes, although research on ATRT is still 
limited (Johnson et al., 2014). 
The third most common group of pediatric brain tumors are germ cell tumors. These tumors 
typically develop in the midline of the brain, near the pineal gland or suprasellar region, and are 
most commonly diagnosed in adolescents (Kieran et al., 2010). Thus, the incidence of germ cell 
tumors is thought to be related to puberty. However, as with all other diagnoses, there is great 
variability across diagnoses. For instance, certain histologies, such as teratomas, are more 
common in infancy and early childhood, whereas germinomas and other germ cell malignancies 
are more common among adolescents (Kieran et al., 2010). Importantly, epidemiological studies 
aimed at identifying more accurate estimates of tumor incidence and survivorship rates continue 
to be underway (Johnson et al., 2014; Kieran et al., 2010; Siegel et al., 2016).  
Brain Tumor Treatments 
Oncological treatments are often complex, with multiple treatment modalities combined to 
enhance their efficacy. The three most common types of treatments are surgery, chemotherapy, 
and radiation. These treatments may occur singularly, or in some combination, depending upon a 
given treatment protocol. Medical organizations, such as the Children’s Oncology Group, have 
developed highly standardized protocols to establish evidence-based guidelines for the best 
course of treatment per tumor type (Breneman et al., 2018).  
Although there are many different types of surgeries performed to diagnose, treat, or relieve 
symptoms of cancer, the two main forms of oncological surgeries are referred to as curative and 
debulking (DeSantis et al., 2014). Curative surgery is used to remove all of the cancer when 





goal is total resection of the brain tumor; however, this may be complicated by the tumor location 
and type. Alternatively, the goal of debulking surgery is partial resection, with the goal to only 
remove some of the cancer. It is used when it would be dangerous too remove an entire tumor, 
due to the potential damage to adjacent organs or tissues (Bruce & Ogden, 2004). In this case, 
surgery is frequently used to reduce the amount of cancer in the body, and is then combined with 
other treatment modalities. In some cases, however, the initial goal of surgery is curative, but 
only partial resection is accomplished. In these cases, adjuvant therapies often become necessary.  
Radiation refers to a treatment that uses high doses of particles or waves to kill or damage 
cancerous cells (DeSantis et al., 2014). It can be combined with other treatments that cause the 
cancer cells to be more sensitive to radiation, and it can shrink a tumor prior to surgery 
(Merchant, Pollack, & Loeffler, 2010). Radiation methods are improving, yet this form of 
treatment is still problematic due to radiation passing through and potentially damaging healthy 
cells in the process (DeSantis et al., 2014). To reduce damage to healthy cells, recent advances 
have led to more focal radiation such as proton therapy, rather than treatments that expose one’s 
entire body to the harmful waves, such photon therapy (Eaton et al., 2016). However, these newer 
treatments still expose healthy cells to radiation, and may continue to cause detrimental side 
effects, including neurocognitive impairments (Eaton et al., 2016).  
Lastly, chemotherapy refers to the use of drugs that target cancer cells at different phases of the 
cell cycle in order to destroy or stop the growth of cancerous cells (DeSantis et al., 2014). This 
treatment is used in a variety of ways, such as to shrink a tumor prior to surgery or to destroy 
cancer cells that remain following irradiation (Mueller & Chang, 2009). It is particularly useful 
for treating metastasized cancers or cancers that have spread throughout the body. However, the 
side effects can be particularly bothersome, since these systemic drugs cannot differentiate 





individual’s body (Mueller & Chang, 2009). Therefore, similar to radiotherapy, there are 
potentially increased risks for long-term late effects following chemotherapy. 
Treatment Approach by Tumor Type 
Due to the variability in tumor locations, grades, and types, an array of treatment protocols has 
been developed, and over time, research has led to the design of more individualistic and tailored 
plans. For instance, different protocols have been developed to treat each of the most common 
pediatric brain tumors (Breneman et al., 2018). 
For pilocytic astrocytomas, surgery is the frontline form of treatment, with the primary goal of 
full resection (Dodgshun, Maixner, Hansford, & Sullivan, 2016). For these tumors, gross total 
resection is related to good prognoses, and subsequent treatments are rarely necessary. When only 
partial resection is achieved, or if the tumor appears to progress, adjuvant chemotherapy may be 
implemented (Bonfield & Steinbok, 2015). However, radiation is not recommended for children 
affected by a pilocytic astrocytoma unless severe progression or relapse occurs. For 
medulloblastomas, treatment commonly consists of a combination of therapies, including curative 
surgery, followed by craniospinal radiation and chemotherapy (Kieran et al., 2010). High-risk 
medulloblastomas require more aggressive forms of chemotherapy and radiation, whereas 
standard-risk may be treated by less aggressive means. For radiotherapy, photon and proton 
radiation appear to have similar disease control outcomes following surgery, but it is important to 
note that proton therapy, as previously mentioned, is thought to be more protective of healthy 
tissues (Eaton et al., 2016).  
Further, cure rates for germinomas are nearly perfect following radiation therapy, but as the 
current understanding of the late effects of treatment has expanded, arguments for different 
treatment modalities have been put forth (Kieran et al., 2010). For instance, the addition of 





allow for success with more focal radiation (Kieran et al., 2010). However, treatments are still 
advancing, and multimodal treatments for more rare, aggressive, or complicated tumors continue 
to be investigated. Advancements in treatment, as it relates to both effectiveness and 
minimization of late effects, are constantly occurring (MacDonald, Aguilera, & Kramm, 2011).  
 Effects of Treatment Approach 
Cancer treatments are known to have a significant impact on quality of life in survivorship. 
Children with brain tumors appear to be at the greatest risk for late effects, as compared to 
children with other cancers, and this risk may be related to differences in the treatment 
approaches taken for central nervous system malignancies versus other cancers (Duffner, 2004; 
Reimers et al., 2003). Specific treatment approaches, or combinations of treatments, appear to 
result in differential late effects (Kingma et al., 2002; Packer et al., 1989; Peterson et al., 2008). 
For instance, children treated with surgery and radiation appear to suffer greater losses than those 
treated with surgery alone (Mulhern, Merchant, Gajjar, Reddick, & Kun, 2004; Packer et al., 
1989). Further, the dose of radiation and volume of the brain that was irradiated also relates to 
outcomes (Kieffer-Renaux et al., 2007; Mulhern et al., 2004). Thus, it is important to consider 
and assess the variability in outcomes of treatment. 
It may be that the differential effects of treatment are variable due to distinct effects on white 
matter volume. Specifically, research has shown that survivors of pediatric central nervous 
system malignancies experience significant damage to white matter tracts in their brains, which is 
related to deficits in neurocognitive functioning, specifically in the domain of processing speed 
(Aukema et al., 2009). This suggests that young children treated for cancer may have a particular 
developmental vulnerability. Radiotherapy, which is known to effect white matter volume, has 
been implicated in these observed impairments. However, one study has shown that white matter 





oncological treatments may have multifaceted effects on the brain (Glass et al., 2017). As 
neurocognitive processes are associated with white matter volume and cortical functionality, 
understanding the unique vulnerabilities of young patients is critical for identifying and 
intervening with those at risk for a host of difficulties in survivorship. 
Neurocognitive Late Effects 
It is well-established that oncological treatments affect a variety of cognitive domains and that 
these effects may vary by disease and demographic characteristics (Fuemmeler, Elkin, & Mullins, 
2002; Mulhern et al., 2004; Turner, Rey-Casserly, Liptak, & Chordas, 2009). The most robust 
evidence documents impairments in processing speed, attentional control, working memory, and 
especially for brain tumor survivors, intellectual functioning. Overall, findings suggest that a 
significant subset of survivors exhibit impairments across neurocognitive domains that are well 
below the performance of healthy age- and gender-matched peers (Mulhern et al., 2004; Reddick 
et al., 2003).  
Processing Speed Impairments 
Processing speed, or the ability to quickly and efficiently manage cognitive operations, appear to 
be particularly important for cognitive functioning, as it underlies domains of higher-order 
functioning (Kahalley et al., 2013; Palmer et al., 2013). Typically, processing speed improves 
over the course of childhood and adolescence as neural circuits mature, and it is posited to be 
closely related to working memory and the development of intellectual functioning (Schatz, 
Kramer, Ablin, & Matthay, 2000). Notably, research shows that pediatric brain tumor survivors 
demonstrate lower processing speed than would be expected for their age, and that processing 
speed may be the cognitive domain with the greatest decline following oncological treatment 
(Kahalley et al., 2013; Palmer et al., 2013). Interestingly, one study found that an untimed 





and reasoning abilities may persist relatively intact following oncological treatment, but that 
declines in processing speed may influence children’s functioning and their ability to develop, 
learn, and achieve (Kahalley et al., 2013). 
Consistent impairments in processing speed have been documented through a variety of 
measurement strategies. Survivors of medulloblastomas tested an average of four years after their 
diagnosis exhibited deficits in processing speed, as measured by the Processing Speed Index 
(PSI) from the Wechsler Intelligence Scale for Children (WISC), as well as slowed movement 
execution (Kieffer-Renaux et al., 2007). Kahalley et al. (2013) found similar results with the PSI 
from the Wechsler Abbreviated Scale of Intelligence (WASI) for adolescent survivors, noting 
slower processing speed to be linked with craniospinal irradiation (Kahalley et al., 2013). A study 
utilizing the Woodcock-Johnson Test of Cognitive Abilities also found that those treated for 
pediatric medulloblastomas demonstrated decreased processing speed following surgical 
resection (Glass et al., 2017). Further, an investigation of survivors of medulloblastomas and 
ependymomas corroborated these findings by employing the Trail Making Test (Spiegler, 
Bouffet, Greenberg, Rutka, & Mabbott, 2004). Decline in performance was estimated to be a loss 
of one standard deviation every three years, indicating that impairments in processing speed 
continue to progress as children age over the course of survivorship.  
Attentional Control 
Attention is a cognitive process that involves being consciously aware of stimuli and the choice 
of what to focus awareness on (Dennis, Hetherington, & Spiegler, 1998). Attention is a 
fundamental capacity that supports other cognitive abilities, including working memory and 
intellectual functioning (Baddeley, 2003). It is also another process that is associated with the 





directly measured by the Wechsler Intelligence Scales, however, the Digit Span Forward score is 
sometimes used as an attention measure.  
More commonly used to evaluate attentional deficits in pediatric brain tumor survivors is the 
Conners’ Continuous Performance Test (CPT), a computerized test that measures sustained 
attention, selective attention, reaction time, and impulsivity (Mulhern et al., 2004; Reddick et al., 
2003). An investigation of white matter volume and attentional difficulties in pediatric brain 
tumor survivors also found that seven out of the ten CPT index scores were impaired, compared 
to age- and gender-matched standard scores (Mulhern et al., 2004). More recently, Glass and 
colleagues (2017) substantiated this finding and suggested that decreased broad attention was 
associated with white matter damage. An examination of both brain tumor and leukemia 
survivors provided further support for the appearance of attention deficits following oncological 
treatment (Hardy, Willard, Wigdor, Allen, & Bonner, 2015). Specifically, these researchers found 
that 27.7% of brain tumor survivors, a subsample much larger than standardized norms, met 
symptom criteria for Attention-Deficit/Hyperactivity Disorder inattentive type (ADHD-I), with 
the most commonly endorsed symptom being “fails to pay close attention to details.” 
Interestingly, investigations of attention deficits in pediatric cancer have sparked a great deal of 
controversy, as some researchers believe that the phenotype of cancer-related attention 
impairments appears consistent with the deficits exhibited by children with neurodevelopmental 
ADHD-I (Hardy et al., 2015). However, others argue that there are important differences between 
neurodevelopmental ADHD and cancer-related cognitive deficits, such that the ADHD model 
would have clinical limitations if applied to survivors (Alderson & Mullins, 2011). In particular, 
changes in the expression of ADHD symptomology across childhood, adolescence, and young 
adulthood, which have not been evidenced in the progression of cancer-related late effects, has 





One study has supported this latter view, by demonstrating that an ADHD diagnostic tool could 
not successfully identify those pediatric cancer survivors who were evidencing difficulties in 
attention (Kahalley et al., 2011). In contrast, an assessment of an ADHD screening tool’s 
predictive validity suggested that an ADHD framework for understanding cancer-related 
neurocognitive deficits could be valuable (Hardy et al., 2015). Another study has also 
demonstrated that brain tumor survivors that have attention difficulties display functional profiles 
that are similar to children with neurodevelopmental ADHD (Hardy, Willard, Gioia, Sharkey, & 
Walsh, 2018). Further, these survivors with attention problems appear to experience greater 
impairments across neurocognitive domains, as compared to those with intact attentional control. 
This suggests that certain profiles of functioning may be observed among survivors, but greater 
research is clearly needed to better ascertain the prevalence of attentional difficulties among 
survivors, as well as the relationship between attention problems and deficits in other areas of 
neuropsychological functioning. 
Working Memory 
Working memory encompasses the ability to register, maintain, update, and manipulate 
information in one’s mind (Dennis et al., 1998). It is considered to be a higher-order function, as 
well as an underlying mechanism of other cognitive capacities, such as intellectual functioning. 
The prefrontal cortex, along with the dorsal anterior cingulate cortex, are the primary brain 
regions that appear to be associated with working memory (Robinson et al., 2009). Importantly, 
these brain regions are continuing to develop throughout adolescence, which may render children 
particularly vulnerable to the effects of oncological treatments on neurocognitive functioning, 
including working memory capacity (Robinson et al., 2009). 
Working memory impairment has been documented by parent- and teacher-report, and 





low (de Vries et al., 2017). The literature suggests that children treated for brain tumors, 
including posterior fossa tumors and medulloblastomas, show reduced cerebral neuro-
connectivity and associated impairments in working memory (Conklin et al., 2013; Law et al., 
2011). Working memory deficits, therefore, appear to be highly related to craniospinal irradiation, 
which is known to damage white matter (Brinkman et al., 2016). Interestingly, recent literature 
has indicated that children with brain tumors may be at risk for cognitive changes even before 
treatment begins. In fact, one investigation found that at diagnosis, children with brain tumors had 
significantly lower working memory performance compared to children with non-central nervous 
system cancers (Margelisch et al., 2015). Perhaps these early changes account, at least in part, for 
the significantly higher risk for poor neurocognitive outcomes among brain tumor survivors, as 
compared to survivors of other pediatric malignancies.  
Limited research seems to indicate that pediatric brain tumor survivors experience deficits in 
multiple cognitive capacities, but that working memory abilities remain intact and are comparable 
to the abilities of healthy peers (Mabbott, Penkman, Witol, Strother, & Bouffet, 2008; Palmer et 
al., 2013). However, the majority of the literature provides supporting evidence that working 
memory deficits exist among pediatric brain tumor survivors, and appear to persist well into 
adulthood with a worsening course (King, Na, & Mao, 2015; Mulhern et al., 2004).  
Intellectual Functioning 
Although associated with deficits in specific underlying domains of cognitive functioning, 
pediatric brain tumors also appear to result in impairments in knowledge acquisition and declines 
in intellectual functioning (Mulhern et al., 2004; Robinson, Fraley, Pearson, Kuttesch, & Compas, 
2013; Spiegler et al., 2004). The literature suggests that the mean intelligence quotient (IQ) for 
survivors of pediatric brain tumors is well below what is found among normative samples (Turner 





children lose an average of 2.2-4.3 IQ points per year (Mulhern et al., 2004). Importantly, 
declines in IQ appear to be directly linked with treatment type. For instance, one study found that 
proton beam radiation was unrelated to changes in IQ, whereas children treated with photon 
radiation experienced a decline of 1.1 IQ points per year (Kahalley et al., 2016). Another review 
found that craniospinal radiotherapy accounted for an average loss of 18 full-scale IQ points 
among survivors, with a progressive decline in IQ over time (Ullrich & Embry, 2012). Taken 
together, these findings suggest that children treated for pediatric brain tumors are at significant 
risk for a variety of neurocognitive impairments, yet there is a lack of specificity in the literature 
regarding the patterns of difficulties that are observed. 
In sum, pediatric brain tumor survivors are at significant risk for reduced neurocognitive 
functioning. Evidence has accrued suggesting impairments in specific domains, including 
processing speed, attentional control, and working memory. However, the profile of such deficits 
is not always consistent in the literature (Conklin et al., 2013; Glass et al., 2017; Kahalley et al., 
2013). Research also suggests that pediatric brain tumor survivors may experience declines in 
intellectual functioning, with disruption in knowledge acquisition and underlying cognitive 
processes by oncological treatment contributing to the elevated risk (Kahalley et al., 2016; Ullrich 
& Embry, 2012). However, the lack of a precision in the current understanding of functional 
profiles among survivors warrants further investigation of the array of neurocognitive difficulties 
pediatric brain tumor survivors may experience.  
Psychosocial Late Effects 
In general, pediatric brain tumor survivors appear to experience risk for both reduced health-
related quality of life and increased global psychological distress (Macartney, Harrison, 
VanDenKerkhof, Stacey, & McCarthy, 2014; Zebrack et al., 2004; Zeltzer et al., 2009). Similar to 





are at the greatest risk for poor psychosocial adjustment when compared to survivors of other 
cancers and healthy siblings, as documented via multiple informants (Patenaude & Kupst, 2005). 
Although most pediatric cancer survivors demonstrate resilience and positive coping, the impact 
of cancer and its treatment on the central nervous system appears to heighten the distress 
experienced by survivors of pediatric brain tumors (Patenaude & Kupst, 2005). This psychosocial 
distress may be exhibited in multiple forms, including internalizing symptoms, externalizing 
symptoms, and social difficulties. 
Internalizing Symptoms 
Internalizing symptoms, including both depressive and anxious symptoms, have been studied in 
the context of pediatric brain tumors. For instance, researchers have found that pediatric brain 
tumor survivors were 1.5 times more likely than their healthy siblings to report depressive or 
anxious symptoms (Schultz et al., 2007), and that those diagnosed in adolescence and early young 
adulthood were up to two times more likely to have depressive or anxious symptoms than their 
healthy siblings (Prasad et al., 2015). However, it is important to note that studies such as these 
that utilize healthy siblings as a comparison group should be considered with caution, as there is 
some evidence suggesting that siblings of children with cancer are also at risk for maladjustment 
(Long et al., 2018). Thus, in the literature utilizing healthy sibling controls, there may be an 
underestimation of the extent of internalizing symptoms experienced by survivors. 
A review of long-term outcomes also found that rates of diagnosed depression and anxiety 
disorders were higher among pediatric brain tumor survivors than normative samples (Shah et al., 
2015). This suggests that not only the prevalence of symptoms, but also the severity of symptoms 
and related impairment may be greater among pediatric brain tumor survivors, such that 
psychiatric diagnoses are found at a higher rate. Further evidence also exists for serious 





suicide attempts (Brinkman et al., 2013). Indeed, estimates suggest that between ten and twelve 
percent of survivors experience suicidal ideation, highlighting the need for a greater 
understanding of suicidality in the context of pediatric brain tumors (Brinkman et al., 2013; Shah 
et al., 2015). 
Notably, specific forms of anxiety have also been documented among this population. For 
instance, treatment anxiety and procedural anxiety are reportedly higher among brain tumor 
survivors as compared to survivors of other cancers (Sato et al., 2014). Across diagnoses, 
pediatric cancer survivors are also at elevated risk for posttraumatic stress disorder (Stuber et al., 
2010). However, those who have received cranial radiation seem to be at particular risk, which 
indicates that pediatric brain tumor survivors are likely to fall in this high-risk group (Stuber et 
al., 2010). Although it has been documented that parents report higher levels of posttraumatic 
stress than survivors, an investigation of youth who have survived a pediatric brain tumor and 
their parents found that over a third of survivors reported clinically significant posttraumatic 
stress symptoms (Bruce, Gumley, Isham, Fearon, & Phipps, 2011; Kazak et al., 2004). These 
symptoms also appear to persist well into adulthood, with one study suggesting that long-term 
survivors are three times more likely than matched-controls to experience clinically significant 
posttraumatic stress symptoms (Seitz et al., 2010).  
Reviews of the literature have also supported the developmental nature of maladjustment, with 
adolescent brain tumor survivors at increased risk for internalizing symptoms (Prasad et al., 2015; 
Turner, et al., 2009). Due to the added social and academic pressures, as well as the increase in 
independence and responsibility typically obtained during this time, adolescents may be 
particularly vulnerable to the psychological distress observed among survivors. However, it is 
important to note that the literature is mixed, and some research seems to suggest that children 
treated for brain tumors may have minimal risk for internalizing symptoms (Fuemmeler et al., 





resiliency model among survivors (e.g., Phipps et al., 2014). However, the extant literature also 
indicates that 30% of adult survivors of childhood cancer show psychological problems, and that 
the estimate may be even higher for survivors of brain tumors (Recklitis, Lockwood, Rothwell, & 
Diller, 2006). Therefore, the current literature would suggest that it is likely that a subset of 
survivors are indeed at risk. However, the literature is difficult to interpret due to variability in the 
measurement methodologies, definitions of symptomology employed, and characteristics of the 
samples in which internalizing symptoms are examined (Fuemmeler et al., 2002). 
Externalizing Symptoms 
Although the literature is much more limited, children treated for brain tumors also appear to 
exhibit higher rates of externalizing symptoms. Such externalizing problems include more general 
behavior problems, aggression, and even conduct disorders (Fuemmeler et al., 2002; Holmquist & 
Scott, 2002; Turner, et al., 2009). A meta-analysis found that the incidence of behavioral 
problems among brain tumor survivors is approximately 28% (Shah et al., 2015). Per parent and 
teacher report, behavioral regulation difficulties appear to be prominent both at home and in 
school, at least for a subset of survivors (Hardy et al., 2018). Parent reports also suggest that 
survivors of astrocytomas may be more likely to exhibit rule-breaking and aggressive behaviors 
(Aarsen et al., 2006). 
Conversely, other reports suggest that children treated for brain tumors may be at minimal or low 
risk for externalizing symptoms as compared to normative samples (Fuemmeler et al., 2002). It is 
suspected that such lowered risk is due to the physical limitations and fatigue associated with 
brain tumors, which may subsequently reduce the ability of youth to engage in behavioral 
outbursts (Fuemmeler et al., 2002). It may also be that externalizing problems are harder to 
identify among youth with certain physical limitations or environmental restrictions. Therefore, 





contribute to the diversity of maladaptive outcomes exhibited by survivors, including predictors 
of those survivors at risk for externalizing difficulties (Holmquist & Scott, 2002).  
Social Problems 
More recently, the literature has turned to a focus on a range of social deficits associated with 
brain tumor survivorship, including difficulties with social competency, antisocial behavior, 
relationships, and social attainment. Poor social competency appears to be a primary affected area 
of functioning. This has been strongly supported by systematic reviews, which demonstrate the 
robust deficits in social competence observed among pediatric brain tumor survivors (Fuemmeler 
et al., 2002; Schulte & Barrera, 2010). One specific study aimed to identify such differences in 
competency, and found that children off-therapy for brain tumors report greater concerns 
regarding social competency than normative samples, and those still in active treatment (Hardy, 
Willard, Watral, & Bonner, 2010). Survivors have also been found to exhibit greater antisocial 
behaviors, paired with reduced social competency, as compared to healthy siblings (Brinkman et 
al., 2012; Schultz et al., 2007). Other investigations have focused on factors that contribute to 
diminished social competence, such as treatment methodologies and impairments in other 
domains, including social-cognitive skills (Schultz et al., 2007; Willard, Allen, Hardy, & Bonner, 
2017). However, it has been suggested that greater research is needed to better define and 
evaluate the precise social impairments that are experienced by pediatric brain tumor survivors. 
Longitudinal evaluations have also sought to delineate the trajectory of social functioning. The 
research shows that social competence appears to decline significantly during the first year 
following treatment and appears to take a worsening course (Brinkman et al., 2012). Pediatric 
brain tumor survivors are also more likely to report having no close friends, as compared to 





they are also likely to be rated as lower in leadership-popularity and higher in sensitivity-isolation 
and victimization than peers (Salley et al., 2015).  
Importantly, as an assessment of the long-term implications of social difficulties following 
pediatric brain tumor treatment, social attainment outcomes in adulthood have also been 
investigated. Research suggests that pediatric brain tumor survivors, compared to siblings and 
survivors of non-central nervous system malignancies, appear to require more special education 
services, are less likely to attend college, and are more likely to be unemployed and unmarried 
(Gurney et al., 2009). Evidence has also accrued that indicates pediatric brain tumor survivors 
exhibit less independent living in adulthood (Kunin-Batson et al., 2011; Maddrey et al., 2005). 
Overall, the variety of these long-lasting and extensive psychosocial difficulties reported warrant 
a greater evaluation of the factors that may uniquely contribute to risk for these outcomes. 
Predictors of Neuropsychological Late Effects 
Across the literature on late effects associated with pediatric brain tumors, numerous predictors of 
negative outcomes have been identified. The majority of these predictors may be characterized 
into three primary categories, including demographic variables, disease variables, and treatment 
variables. Although some have been mentioned thus far, the most salient and robust predictors are 
summarized below. 
Demographic Variables 
Age at diagnosis, as well as time since diagnosis, appear to be important predictors of 
neuropsychological outcomes. In general, it appears that younger age at diagnosis and greater 
time since diagnosis are associated with worse outcomes (Fuemmeler et al., 2002; Turner, et al., 
2009; Zeltzer et al., 2009). In particular, younger age at diagnosis is a salient predictor of 
impairments across domains of neurocognitive functioning (Spiegler et al., 2004). Since younger 





treatment, it is suspected that they exhibit greater deficits than their older counterparts. These 
impairments in cognitive functioning may then be exacerbated as the children age and struggle to 
learn at the same rate as their peers (Spiegler et al., 2004). Further, the rate of decline in IQ 
appears to be related to age at diagnosis, with those who were diagnosed younger exhibiting 
greater decline (Mulhern et al., 2004). Overall, a longer time since diagnosis appears to be linked 
with worse intellectual outcomes (De Ruiter, Van Mourik, Schouten-Van Meeteren, Grootenhuis, 
& Oosterlaan, 2013). Alternatively, other reports suggest that older age at diagnosis, such as 
above eleven years old, may be related to worse psychosocial outcomes (Prasad et al., 2015). This 
indicates that age or time may differentially predict the diverse neuropsychological sequelae 
experienced by pediatric brain tumor survivors. 
Much of the literature also indicates that females are at greater risk for neuropsychological 
difficulties. Females evidence greater declines in intellectual functioning and processing speed 
than males following pediatric brain tumor treatment (Von der Weid et al., 2003; Waber et al., 
2010; Zebrack et al., 2004). An increased rate of decline in IQ has also been associated with 
female sex (Mulhern et al., 2004). Specific neuropsychological difficulties, including task 
efficiency and emotional regulation, have also been found to be related to female sex (Ellenberg 
et al., 2009). Similar to the general population, female sex also appears to be a risk factor for 
greater psychological distress (Zebrack et al., 2004). It is possible that female brains have a 
greater vulnerability to the effects of oncological treatments, due to hormonal differences (Jain, 
Brouwers, Okcu, Cirino, & Krull, 2009). However, the research is not entirely consistent, such 
that some investigations have shown that male survivors evidence greater impairments in 
processing speed, inhibitory control, and working memory (Jain et al., 2009; Kahalley et al., 
2013). 
Other factors, such as parent education, appear to also have unique patterns of relationships with 





greater social competence at diagnosis, but experience a greater decline in competency following 
treatment (Brinkman et al., 2012). However, Palmer and colleagues (2013) found that parent 
education was associated with higher baseline neurocognitive functioning, but was unrelated to 
change in neurocognitive functioning among survivors over time. Further, another study found 
that parental education was associated with achievement across academic domains for pediatric 
brain tumor survivors, but was unrelated to the difference observed between survivors and 
healthy peers (Ach et al., 2013). This may mean that parental education may be related to 
baseline functioning, but other factors may account for the subsequent declines exhibited by 
survivors. 
Socioeconomic status may have a similar relationship with neuropsychological outcomes. For 
instance, Ach and colleagues (2013) also found that socioeconomic status was related to cognitive 
functioning, but was unrelated to the relative deficit experienced by survivors. However, it is 
important to note that parental education is often used as a proxy for socioeconomic status, thus 
confounding some of these results (e.g., Reeves et al., 2005). Although, lower levels of 
socioeconomic status do seem to have a significant association with greater levels of distress 
among brain tumor survivors, as would be expected given what is known about the general 
population (Zebrack et al., 2004). Importantly, there may be other mediating relationships with 
these factors, such that socioeconomic status and parent education relate to other family and 
patient factors that add to a child’s risk for negative outcomes (Copeland, Moore, Francis, Jaffe, 
& Culbert, 1996). 
Disease Variables 
Research on the relationship between disease variables or parameters and neuropsychological 
outcomes in the context of pediatric brain tumors appears to be more well-documented, 





impairment. For instance, the disease variable of diagnosis is a particularly salient predictor, as 
the literature consistently demonstrates that survivors of pediatric brain tumors are at the greatest 
risk for maladjustment and neurocognitive sequelae, as compared to survivors of other cancers 
(e.g., Duffner, 2004; Macartney et al., 2014; Sato et al., 2014; Zeltzer et al., 2009). At the same 
time, some studies exist that suggest a lack of relationship between disease characteristics and 
late effects, indicating that further evaluation of the factors that contribute to different risk 
profiles is needed (De Ruiter et al., 2013).  
Among those disease variables posited to be associated with increased risk is tumor location, with 
cerebral tumors resulting in greater cognitive deficits (Reimers et al., 2003). It has also been 
suggested that children treated for infratentorial tumors are at greater risk for neurocognitive 
deficits, particularly in the domains of inhibitory control and attention (Brinkman et al., 2016; 
Raghubar et al., 2017). Meanwhile, others have found that supratentorial tumors and those 
located in the hypothalamic or chiasmatic regions resulted in greater risk for psychosocial 
adjustment difficulties (Fuemmeler et al., 2002). Interestingly, as tumor type and location vary by 
age, it is possible that there is an interaction between age and tumor location effecting 
neuropsychological outcomes (Kieran et al., 2010). 
Tumor-associated medical complications are also strong predictors of negative outcomes. For 
instance, declines in IQ are linked with hydrocephalus, or a build-up of fluid in the brain, which 
occurs frequently with brain tumor patients (Mulhern et al., 2004). Ventriculoperitoneal shunt 
placement, due to hydrocephalus, is also linked with poorer neurocognitive functioning 
(Ellenberg et al., 2009). A more recent investigation supported this finding, indicating that 
hydrocephalus with shunt placement was related to a 40% increase in risk for impaired 
intelligence and memory (Brinkman et al., 2016). Cerebellar mutism syndrome, or posterior fossa 
syndrome, is also strongly related to a host of neurocognitive impairments (Palmer et al., 2010). 





suggesting that it may be a combination of factors that heighten the risk experienced by survivors 
(De Ruiter et al., 2013). 
Treatment Variables 
Lastly, multiple treatment-related variables are linked with neuropsychological late effects among 
pediatric brain tumor survivors. The most robust predictor of negative outcomes is radiotherapy 
(Fuemmeler et al., 2002; Turner, et al., 2009). The literature has consistently shown that radiation 
therapy results in the greatest risk for cognitive decline and the most severe impairments (Kingma 
et al., 2002; Packer et al., 1989; Peterson et al., 2008). Radiation has been shown to result in 
deficits across working memory and attention tasks, including Digit Span from the WISC and the 
Stroop Color-Word Test (Harila, Winqvist, Lanning, Bloigu, & Harila-Saari, 2009). When 
comparing the effects of surgery alone and surgery combined with radiation, children who 
underwent the combined treatment were the ones who displayed the greatest losses (Packer et al., 
1989). 
Treatment approach also influences white matter volume. Children treated with chemotherapy-
only maintain greater volumes of white matter than those treated with radiation, suggesting that 
the effects of radiation are long-lasting and pervasive (Reddick et al., 2003). Thus, chemotherapy-
only appears to result in fewer and less severe deficits than a combined chemotherapy and 
radiation protocol (Von der Weid et al., 2003). However, chemotherapy-only is a rare treatment 
plan for brain tumors; thus, the inclusion of surgery and radiation as treatment modalities may be 
contributing to the neuropsychological difference between survivors of brain tumors and other 
cancers. Further, cerebellar mutism syndrome appears to be a complication following certain 
treatments, suggesting that there may be an interaction between treatment-related and disease-





Treatment intensity, including dose of radiation or chemotherapy, is also significantly related to 
neurocognitive deficits. Larger radiation dose and greater volume of irradiated brain have been 
identified as risk factors for decline in intellectual functioning (Kieffer-Renaux et al., 2007; 
Mulhern et al., 2004). Survivors receiving high-dose cranial radiation had significantly more 
problems with attention, processing speed, memory, and emotion regulation (Zeltzer et al., 2009). 
Craniospinal irradiation dose also appears to predict worse social functioning among survivors 
(Brinkman et al., 2012). New advancements in medical treatments have led to more focal 
irradiation, which is purported to result in improved long-term outcomes for patients. 
Specifically, research has suggested that children treated with proton radiation show minimal 
changes in IQ, whereas children treated with photon radiation experience a significant decline 
(Kahalley et al., 2016). Thus, continued assessment of neuropsychological outcomes is needed in 
order to parallel the rapidly changing medical landscape. 
Relationships Across Domains 
Evidently, there is a complex interplay between risk factors for neuropsychological sequelae, 
which may have varying relationships across domains of neurocognitive and psychosocial 
functioning. However, the majority of the literature on late effects for pediatric brain tumor 
survivors appears to present neurocognitive and psychosocial outcomes as distinct sets of 
symptoms, and rarely are relationships assessed between these areas of functioning, despite clear 
evidence of elevated risk in both domains. Many studies have examined neurocognitive deficits 
(e.g., Kahalley et al., 2013), whereas other studies investigate the psychosocial impact of 
pediatric brain tumors and its treatment (e.g., Gurney et al., 2009), without reference to the other 






On the other hand, some studies have evaluated both neurocognitive and psychosocial outcomes, 
yet the different domains are often reported independently. For instance, MaCartney and 
colleagues (2014) and De Ruiter and colleagues (2013) reported on psychological, social, and 
cognitive domains of quality of life, but did not evaluate overall profiles of impairment between 
domains. Schultz and colleagues (2007) reported on the relative risk for outcomes, such as 
depression, anxiety, and attention difficulties, without examining the potential relationship 
between these outcomes. Similarly, Prasad and colleagues (2015) utilized the Brief Symptom 
Inventory and a neurocognitive questionnaire to assess problems across domains of functioning, 
but neglected to examine correlations across the different measures. Indeed, the authors refer to 
the intercorrelation between reports of neurocognitive and psychological functioning as a 
limitation in the study, rather than evaluating and providing interpretations of these relationships. 
Further, reviews of the literature highlight the significance of both neurocognitive and 
psychosocial late effects, yet these papers exemplify the clear separation between the domains 
(e.g., Fuemmeler et al., 2002; Turner et al., 2009).  
However, it is important to note that limited research has, to some extent, evaluated the 
relationship between neurocognitive and psychosocial outcomes. For example, Hardy and 
colleagues (2018) evaluated the prevalence of parent- and teacher-reported internalizing and 
externalizing behaviors among brain tumor survivors with and without attention difficulties. 
Although the direct relationship between these outcomes was not assessed, this study provides 
preliminary support for a relationship between neurocognitive and psychosocial outcomes. 
Associations between intellectual functioning and psychological and behavioral symptoms, as 
well as social deficits and neurocognitive impairments have also been identified among pediatric 
brain tumor survivors (Poggi et al., 2005; Schulte & Barrera, 2010; Willard et al., 2017). Another 
recent study has also found correlations between executive functioning and quality of life, but 





such as family functioning, have also begun to be investigated as potential links between 
neurocognitive and psychosocial impairments (Hocking, Hobbie, Deatrick, Hardie, & Barakat, 
2015).  
Taken together, these findings indicate that relationships do exist between the neurocognitive and 
psychosocial late effects exhibited by brain tumor survivors. Further, the identification of shared 
risk factors for a variety of late effects, including child sex, age, and tumor location, suggests that 
subsets of survivors may have unique risk for certain clusters of impairments that extend across 
domains (e.g., De Ruiter et al., 2013; Fuemmeler et al., 2002; Zeltzer et al., 2009). However, the 
literature on these interrelationships is limited, and appears to focus on only specific aspects of 
functioning, such as quality of life or social competency (e.g., Netson et al., 2016; Schulte & 
Barrera, 2010). Investigations on associations across domains and predictors of such symptom 
profiles is clearly lacking. The complex and inconsistent findings regarding specific outcomes 
and risk factors may indicate that an assessment of the more intricate relationships between 
outcomes, beyond simple correlations, is needed. 
Summary 
Brain tumors, which encompass a wide variety of histologies, are the second most common 
cancer diagnosis among youth (Kieran et al., 2010; Siegel et al., 2016). Advancements in 
treatment protocols are ever-evolving, facilitating improved prognoses and long-term survival of 
children treated for pediatric brain tumors (DeSantis et al., 2014; Kieran et al., 2010; MacDonald 
et al., 2011). However, the robust literature suggests that survivors of pediatric brain tumors 
experience significant risk for neuropsychological late effects (Fuemmeler et al., 2002; Mulhern 
et al., 2004; Turner, et al., 2009; Zebrack et al., 2004; Zeltzer et al., 2009). Commonly observed 
impairments include reduced processing speed and attentional control, declines in intellectual 





difficulties, and decreased social attainment in adulthood (Barrera et al., 2005; Brinkman et al., 
2012; Gurney et al., 2009; Hardy et al., 2015; Kahalley et al., 2013, 2016; Macartney et al., 2014; 
Shah et al., 2015). The risk for these sequelae appears to vary by child age at diagnosis, child sex, 
tumor location and type, medical complications, and treatment approach (Ellenberg et al., 2009; 
Kahalley et al., 2016; Palmer et al., 2010; Prasad et al., 2015; Raghubar et al., 2017; Turner, et 
al., 2009).  
However, risk for the full constellation of late effects that pediatric brain tumor survivors may 
experience has received limited attention. Difficulties in neurocognitive and psychosocial 
functioning are often examined discretely in the literature, resulting in little understanding of the 
global patterns of late effects that are exhibited by survivors (Fuemmeler et al., 2002; Turner, et 
al., 2009). Thus, the current study aimed to evaluate the neuropsychological profiles of pediatric 
brain tumor survivors, and to examine predictors of these phenotypes, in an effort to better 









Participants and Procedures 
Participants are youth (N = 89) who are pediatric brain tumor survivors and were assessed within 
the pediatric neuropsychology clinic of an academic medical center in the Mid-Atlantic region 
between May 2009 and May 2018. Participants were eligible if they: (1) had a diagnosis of a 
brain tumor at or before the age of 18, (2) were diagnosed at least one year prior, and off-
treatment for at least three months at the time of assessment, and (3) had a comprehensive 
evaluation conducted, which included both parent- and teacher-report of symptoms, and 
performance-based measures. All participants provided informed consent to have their records 
entered and stored in a database intended to be utilized for research purposes. Institutional review 
board approval was obtained to abstract demographic, medical, neurocognitive, and psychosocial 
data from the medical records of brain tumor survivors. All procedures adhered to the American 
Psychological Association’s ethical guidelines. 
Measures 
Demographic and disease characteristics.  
Demographic and disease characteristics were abstracted from the medical records of all brain 
tumor survivors. Relevant demographic data included child sex, child age at diagnosis, child age 





socioeconomic status were not consistently reported, and were therefore not abstracted. Relevant 
disease characteristics included brain tumor diagnosis, time since diagnosis, time since treatment 
completion, treatment types (i.e., radiation, surgery, chemotherapy), and the diagnoses of 
hydrocephalus, posterior fossa syndrome, and neurofibromatosis 1 (NF1). Tumor location, 
radiation dose, and chemotherapy type were not consistently reported, and were therefore not 
abstracted. For analytic purposes, all demographic and disease variables were dichotomized (e.g., 
race was dichotomized as Caucasian or non-Caucasian).  
Parent and teacher ratings. 
Child Behavior Checklist (CBCL) and Teacher Report Form (TRF). The CBCL (Achenbach & 
Edelbrock, 1991) and TRF (Achenbach & Rescorla, 2001) are parent- and teacher-report 
measures, respectively. These questionnaires assess the emotional, behavioral, and psychosocial 
functioning of children between the ages of six and eighteen with Likert scale items and 
competency ratings. Parent- and teacher-ratings were converted to T-scores, based on the 
standardization sample of same-aged peers. Higher T-scores suggest a greater degree of 
impairment, with T-scores above 63 considered to be in the Clinical range and those below 
considered to be normative. Parent- and teacher-reports of the Internalizing Problems and 
Externalizing Problems composite scores, as well as the Social Problems subscale score were 
used for analyses. The CBCL and TRF have shown very high inter-interviewer reliability and 
test-retest reliability, with good to excellent internal consistency among the scales to be utilized in 
the current study (Achenbach & Rescorla, 2001). 
Performance-based measures. 
Wechsler Scales of Intelligence. The Wechsler Scales of Intelligence provide an overall 
assessment of intellectual functioning, as well as measures of specific intellectual abilities 





course of a decade, intellectual functioning was assessed using the most recent age-appropriate 
version of the Wechsler Scales that was available at the time of assessment. The majority of 
participants completed the Wechsler Intelligence Scale for Children-Fourth Edition (WISC-IV; 
12.36%) or the Wechsler Intelligence Scale for Children-Fifth Edition (WISC-V; 62.92%). From 
each version a test of immediate/working memory (Digit Span subtest), and the Processing Speed 
Index (PSI) were utilized. The Digit Span subtest is standardized to have an average of 10 and a 
standard deviation of 3, with scores below 6 falling in the “Below Average” range or lower. The 
PSI is standardized to have an average score of 100, and a standard deviation of 15, with scores 
below 80 considered to be in the “Below Average” range or lower. The Wechsler scales have 
demonstrated excellent test-retest reliability and good to excellent internal consistency across 
subtests and index scores (Wechsler, 2014). 
Tower of London-DX-Drexel Version (TOL). The TOL measures visual planning and problem-
solving skills among individuals seven-years-old and older, and is employed as a measure of 
executive functioning (Culbertson & Zilmer, 2005). Raw scores are observed during 
administration and are converted to normative standard scores. The Total Moves and Total 
Problem-Solving Time standard scores were used in analyses in the current study and assess skills 
in visual planning and problem-solving. The TOL has been shown to have acceptable test-retest 
reliability and internal consistency, as well as strong convergent and divergent validity 
(Culbertson & Zilmer, 2005). 
Overview of Statistical Analyses 
Descriptive and summary statistics were first used to detail the prevalence of neurocognitive 
deficits and clinically significant psychological distress, utilizing standardized cut-off 
recommendations. Bivariate correlations were conducted to determine if there were detectable 





Latent profile analysis (LPA), a person-centered data analytic approach, was conducted using 
Mplus version 8.1 to identify subgroups based on the observed response and performance patterns 
across the ten neurocognitive and psychosocial indicators (Berlin, Williams, & Parra, 2014).  The 
indicators included both Parent-and Teacher-Reported Internalizing Problems, Externalizing 
Problems, and Social Problems, child performance on the Total Moves and Total Problem-
Solving Time scores from the TOL, the Digit Span subtest from the Wechsler scales and the PSI 
from the Wechsler scales.  Using maximum likelihood estimation with robust standard errors, 
LPA produces the probability of an individual’s membership in each class of symptom profiles 
and estimates the most likely group membership. The classes consist of individuals with similar 
means on the ten continuous indicators.  
Due to the flexibility and maximal information accounted for by LPA, model fit optimization was 
evaluated based on substantive theory and model fit criterion.  Classes were added iteratively and 
the feasibility of 1-, 2-, 3-, 4-, and 5-class solutions were examined. Relative model fit was 
assessed by the Vuong-Lo-Mendell-Rubin Adjusted Likelihood Ratio Test (VLMR), and the 
parametric bootstrapped likelihood ratio difference test (BLRT; Nylund, Asparouhov, & Muthén, 
2007).  For these tests, p-values less than .05 were assumed to indicate that a model with one 
additional class was a better fit than a model with one less class.  As differences in likelihood 
ratio tests are likely to arise, preference was given to the BLRT, as it has been shown to produce 
more consistent results regarding class optimization (Nylund, Asparouhov, & Muthén, 2007).  
Entropy and information criteria were also employed to assess model fit optimization.  Entropy 
values closer to one indicate greater accuracy of classification, and thus solutions with higher 
entropy values were considered preferable (Geiser, 2013).  The Bayesian Information Criteria 
(BIC), Akaike Information Criteria (AIC), and Sample Size Adjusted-BIC (SSA-BIC) were also 
evaluated, with lower values indicating better fit (Geiser, 2013). Additionally, a difference greater 





less class was considered to suggest a sufficient improvement in model fit (Raftery, 1995). If fit 
indices were discrepant, preference was given to the BIC and SSA-BIC (Henson, Reise, & Kim, 
2007; Nylund et al., 2007). Additionally, replication of the best log-likelihood was confirmed for 
each model to avoid local maxima. The null model log-likelihood for the BLRT was also verified 
as equivalent to the best log-likelihood value of the model with one less class. 
After the optimal class solution was identified, one-way ANOVAs with post-hoc Bonferroni tests 
were conducted to compare the means of participants’ psychosocial and neurocognitive scores 
between the latent classes, in order to test for independence of samples. Lastly, the R3STEP 
procedure, which employs multinomial logistic regression, was utilized to assess predictors of 
class membership (Asparouhov & Muthén, 2015).  Specifically, demographic variables including 
child sex, child race and ethnicity, and disease variables, including age at diagnosis, treatment 










The final sample included eighty-nine survivors of pediatric brain tumor who were diagnosed at 
an average age of 6.57 years (SD = 4.53; Mage at evaluation = 12.60, SD = 4.41). The most common 
diagnosis was pilocytic astrocytoma (28.1%), followed by Medulloblastoma (21.3%), and the 
majority of the sample were treated with surgery (84.3%) and at least one other treatment type. 
Patients were primarily Caucasian (71.9%) and nearly half were female (46.1%). Demographic 
and disease characteristics are detailed in Table 1.  
Descriptive statistics demonstrated that, overall, the sample was functioning in the average range 
(T<63) for psychosocial difficulties, according to both parent- and teacher-report measures. 
However, psychosocial difficulties were evident for a subset of patients, with 20.5% of parents 
reporting clinically concerning internalizing symptoms.  Neurocognitive impairments were 
significant across measures of executive functioning, processing speed, and working memory, 
with nearly 30.00% of the sample demonstrating a deficit in each domain. See Table 2 for 
descriptive statistics. Bivariate correlations demonstrated some associations between 
neurocognitive variables and psychosocial outcomes, but the strength of these correlations and 
significance varied across domains of functioning and informant; thus, the use of LPA was 





Latent Profile Analysis 
Models ranging from one to five classes were identified based on the ten indicators, and the 
model with four classes was found to have optimal fit. VLMR and BLRT differed in significance, 
so preference was given to the significant BLRT value (p < 0.001). AIC and BIC values both 
suggested a four-class solution, with a sufficient change in BIC (Raftery, 1995). Entropy was 
strong for the four-class solution (0.89), and none of the class sample sizes were too small (<5%). 
Fit statistics can be found in Table 4.  
The largest class (n = 47, 52.81% ) was termed the “Average” group, and was characterized by 
average functioning across all domains (i.e., average CBCL and TRF t-scores < 63; TOL and 
Wechsler scores in the Average range). The second largest class (n = 25, 28.09%) was termed the 
“Cognitive Deficit” group, as this group was distinguished by average psychosocial functioning 
(i.e., average CBCL and TRF t-scores < 63), yet evidenced some impairments in neurocognitive 
functioning (e.g., MPSI = 78.65). The third group (n = 9, 10.11%) was characterized by elevated 
social problems (i.e., average CBCL and TRF Social Problems t-scores > 63) and significant 
neurocognitive impairments (e.g., MDigit Span = 5.14; MTotal Problem-Solving Time = 70.48), and was 
therefore termed the “Social/Cognitive Deficit” group. The final group (n = 8, 8.99%) was termed 
the “Discrepant” group, as it was characterized by elevated parent-reported Internalizing, 
Externalizing, and Social Problems (average CBCL t-scores > 63), and difficulties in visual 
planning and problem-solving (i.e., MTotal Problem-Solving Time = 77.20; MTotal Moves score = 72.08). 
However, it is important to note that the “Discrepant” group demonstrated average processing 
speed and working memory (MPSI = 94.56; MDigit Span = 10.40). Figure 1 provides a graphical 
representation of profile means across domains. 





All one-way ANOVAs comparing the ten psychosocial and neurocognitive indicators were 
significant (p’s < 0.001), suggesting strong independence of profiles. Post-hoc Bonferroni tests 
were used with the “Average” group as the reference. Tests showed that the “Average” group 
scored significantly better (p’s < 0.05) than all three of the other profiles across domains, with a 
few exceptions. The “Average” group did not differ from the “Cognitive Deficit” group (p = 
1.00) or the “Social/Cognitive Deficit” group (p = 0.696) on the parent-reported Internalizing 
Problems scale. Additionally, the “Average” group did not differ from the “Cognitive Deficit” 
group (p = 0.075) or the “Discrepant” group (p = 1.00) on the Digit Span subtest, and did not 
differ from the “Discrepant” group on the PSI (p = 1.00). As was previously noted, the 
“Discrepant” group did not demonstrate deficits in the working memory and processing speed 
domains. 
Predictors of Class Membership 
Using the R3STEP Procedure, the “Average” group was chosen as the reference category, since it 
was the largest class with the highest functioning across measures. See Table 5 for odds 
estimates. 
Demographics. Ethnicity predicted class membership, with those who were Hispanic/Latino less 
likely to be in the “Cognitive Deficit” group, as compared to the “Average” group (B = -24.03, 
SE = 1.65, p < 0.001). Those who were Hispanic/Latino were also more likely to be in the 
“Discrepant” group, as compared to the “Average” group (B = 26.59, SE = 1.65, p < 0.001). Race 
also predicted class membership, with those who are Caucasian having higher odds of being in 
the “Discrepant” class than the “Average” class (B = -27.95, SE = 0.00, p < 0.001). Child sex did 





Treatment Variables.  Those treated with radiation had lower odds of being in the “Discrepant” 
group, as compared to the “Average” group (B = -28.80, SE = 0.00, p < 0.001). Chemotherapy 
and surgery did not significantly relate to class membership, relative to the “Average” group. 
Disease Variables. A diagnosis of NF1, hydrocephalus, and Posterior Fossa Syndrome, 
significantly predicted class membership. Relative to the “Average” group, those with NF1 had 
higher odds of being in the “Social/Cognitive Deficit” group (B = 25.26, SE = 3.93, p < 0.001), 
the “Cognitive Deficit” group (B = 22.63, SE = 3.11, p < 0.001), and the “Discrepant” group (B = 
25.24, SE = 0.00, p < 0.001). Those with hydrocephalus had lower odds of being in the 
“Discrepant” class, compared to the “Average” class (B = -23.48, SE = 0.00, p < 0.001). Lastly, 
those with Posterior Fossa Syndrome also had lower odds of being in the “Discrepant” group, 
relative to the “Average” group (B = -13.89, SE = 0.00, p < 0.001). It is important to note that no 
patient with NF1 had a diagnosis of hydrocephalus and/or Posterior Fossa Syndrome, which may 
explain why those with hydrocephalus and/or Posterior Fossa Syndrome were unlikely to be 
members of the “Discrepant” group. Age at diagnosis and time since diagnosis did not 










The current study evaluated psychosocial and neurocognitive functioning among pediatric brain 
tumor survivors across multiple domains via multi-method assessment, thus providing a 
comprehensive overview of the broad neuropsychological late effects. Findings were consistent 
with the extant literature regarding the risk for impairments among survivors, with 20.5% of the 
current sample demonstrating elevated parent-reported internalizing symptoms, and 
approximately one-third of the sample showing executive functioning deficits. However, the 
present study expanded upon these findings by delineating specific phenotypes of psychosocial 
and neurocognitive outcomes among survivors. By examining observed symptom profiles, these 
findings shed light on patterns of relations among neuropsychological domains that might have 
been missed by traditional statistical analyses that rely on correlations alone. Thus, this study is 
the first to employ this novel approach to understanding the complex and non-linear patterns of 
symptomology that are experienced in survivorship. 
Four distinct profiles of psychosocial and neurocognitive functioning were identified. 
Approximately half of the sample (52.81%, “Average” class) was found to be functioning within 
normal limits across both neurocognitive and psychosocial measures, whereas the remaining half 
demonstrated impairments in at least one domain. The “Average” group may be conceptualized 





that this group represents youth who were functioning in the above average range prior to their 
brain tumor diagnosis and treatment, and therefore have suffered some treatment-related 
impairments. Thus, consideration of these profiles in relation to premorbid functioning is 
necessary, and would be facilitated by future prospective investigations. 
 Aligned with the robust literature demonstrating neurocognitive difficulties among pediatric 
brain tumor survivors, the “Cognitive Deficit” class (28.09%) was the second largest class, 
defined by deficits across performance-based measures of neurocognitive functioning (Glass et 
al., 2017; Mulhern et al., 2004; Turner et al., 2009). Meanwhile, the “Social/Cognitive Deficit” 
class (10.11%) was distinguished by additional impairments in social functioning, per parent- and 
teacher-report. Thus, the distinction of this group is consistent with recent literature suggesting 
that a significant subset of survivors exhibit impairments, relative to typically developing 
children, in social competency and specifically in social-cognitive skills that require abilities to 
process information about others and social situations (Fuemmeler et al., 2002; Schulte & 
Barrera, 2010; Willard, Allen, Hardy, & Bonner, 2017).  
Lastly, the “Discrepant” class (8.99%) demonstrated significantly elevated psychosocial 
difficulties across domains per parent-report, as well as deficits in visual planning and problem-
solving skills. Interestingly, the “Discrepant” class was functioning in the average range, per 
teacher-report, and did not exhibit impairments in working memory or processing speed. As 
previous research has shown that reports of psychosocial outcomes often vary based on informant 
and assessment methodology, it is advantageous that the current study synthesized information 
from multiple sources to ascertain a more clear pattern of impairments (Ellenberg et al., 2009; 
Hardy et al., 2018; Kapella et al., 2015; Zebrack et al., 2004). The present finding that parent- and 
teacher-report of symptomology do not align for the “Discrepant” group highlights the need for 
data from multiple informants, in order to optimize the benefit of neuropsychological surveillance 





Consistent with the preventative model put forth by Hardy and colleagues (2017), the current 
study also aimed to identify observable factors that predict specific patterns of 
neuropsychological functioning. Importantly, the current findings suggest that children with a 
NF1 diagnosis were disproportionately represented in the “Discrepant” group. Previous research 
suggests that children with NF1 exhibit uneven neuropsychological profiles, with significant 
deficits in some domains while other abilities remain intact (Potvin, Hardy, & Walsh, 2015). 
Further, the literature suggests that psychosocial problems are prevalent, yet teachers appear to 
report fewer difficulties than parents among this population (Johnson, Saal, Lovell, & Schorry, 
1999; Murray et al., 2007). Although the specific pattern of neurocognitive impairment observed 
in the current study differs from some previous reports, the uneven profiles and higher parent-
reported problems exhibited by the “Discrepant” group provides support for the understanding 
that those with NF1 do indeed evidence a distinct phenotype (Potvin, Hardy, & Walsh, 2015). 
Other predictors of class membership included ethnicity, race, treatment with radiation, and 
diagnoses of hydrocephalus or posterior fossa syndrome. In terms of demographics, it was found 
that those who were Hispanic/Latino and those who were Caucasian were more likely to be in the 
“Discrepant” group, compared to the “Average” group. However, it is important to note that 
variability in race and ethnicity was quite low, suggesting that these differences may not 
accurately reflect a specific ethnic or racial group’s vulnerability to be classified into a certain 
group. It was also found that those who received radiation treatment were less likely to be in the 
“Discrepant” group, relative to the “Average” group. At first glance, this result may be surprising 
as radiation treatment is known to be associated with poorer neurocognitive outcomes (Mulhern, 
Merchant, Gajjar, Reddick, & Kun, 2004). However, current research suggests that those with 
NF1 are at greater risk for radiation-related complications (Grill, Dhermain, & Habrand, 2009). 





populations align with the finding that the “Discrepant” group was less likely to receive this form 
of treatment.  
Lastly, those with hydrocephalus or posterior fossa syndrome were less likely to be in the 
“Discrepant” class, as compared to the “Average” class. This finding may also be surprising, as 
hydrocephalus and posterior fossa syndrome are medical challenges that are often associated with 
cognitive impairments. The most parsimonious explanation is that these diagnoses are less 
common among those with NF1, and thus those with hydrocephalus or posterior fossa syndrome 
would certaintly have lower odds of being members of the “Discrepant” group. Overall, it 
appeared that these diagnoses did not differentiate between the other three classes, and therefore 
may not contribute greatly to the experience of a specific symptom profile. Further examination 
of the extent of medical challenges related to these diagnoses, as well as the treatments utilized, 
would foster a greater understanding of how hydrocephalus and posterior fossa syndrome may 
relate to neurocognitive and psychosocial late effects in this population.  
Although the current study aimed to identify strong predictors of class membership, the present 
findings underscore the need for more consistent reporting of demographic and illness-related 
variables. Understanding the effect of ethnic/racial background and specific diagnoses on 
neuropsychological profiles is beneficial, yet knowledge of other factors such as tumor location, 
socioeconomic status, and radiation dose could have added to the clinical utility of the current 
evaluation. Although these predictors are not modifiable factors, they would likely facilitate 
targeted screening and subsequent early intervention for those individuals at risk for specific 
profiles that consist of varying impairments. For instance, knowledge of tumor location may 
distinguish those youth likely to be in the “Cognitive Deficit” class, from youth with additional 
risk for social problems (i.e., “Social/Cognitive” class), which could aid in clinical decisions 





The present study adds greatly to the literature on the interrelationships between neurocognitive 
and psychosocial late effects, yet there are some limitations that necessitate the replication of 
these findings and subsequent confirmation of the neuropsychological profiles that are delineated 
here. In particular, confirmatory analyses of these profiles among both larger samples, and more 
diverse samples is indicated, especially in regard to demographic and disease characteristics. 
Additionally, replication among more homogenous groups, such as particular age groups or tumor 
types, is warranted. As the current study consists of a clinic-referred sample, these children may 
be more economically advantaged, or may be more impaired than the general survivorship 
population, further necessitating assessment of samples from other referral sources. In addition, it 
is noted that this preliminary study conducted with a sample size less than 100 should be 
interpreted with caution when considering generalizability of the findings (Wurpts & Geiser, 
2014).  However, small sample size was adequately compensated for, as the current sample size 
was above the minimum necessary (>70), the profiles were shown to have strong independence, 
and a large number of indicators were utilized. 
Prospective evaluations of youth, starting with initial assessments prior to treatment, would also 
be beneficial, especially as untoward effects of surgery have been documented, even prior to 
radiotherapy or chemotherapy (Glass et al., 2017). Additionally, the parent- and teacher-report 
measures, as well as the performance-based assessments, chosen for this investigation were based 
on the data available due to the standard assessment battery utilized in the neuropsychology 
clinic.  Prospective assessments specifically designed to include a more extensive battery of 
measures would be advantageous. Future examinations of the change in neuropsychological 
functioning experienced by these distinct classes will also provide greater insight into the need for 
targeted screening and intervention. It is also essential that additional predictors of class 
membership are examined, as this would add to the clinical utility of the observed phenotypes. 





design of optimally tailored interventions. Investigation of parent factors, such as parent distress, 
which are known to relate to child psychological outcomes, may also lead to a greater 
appreciation for the need for family-centered care (Drotar, 1997). Thus, the current study is a 
preliminary step toward the future development of effective and efficient assessment and 
treatment of pediatric brain tumor survivors who are at significant risk for specific patterns of 
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Table 1. Demographic and illness information of sample (N = 89) 
Variables N/M %/SD 
Gender   
     Female 41 46.1% 
Race/Ethnicity   
     Caucasian 64 71.9% 
     African-American 12 13.5% 
     Asian 5 5.6% 
     Native American 1 1.1% 
     Multi-Racial 2 2.2% 
     Other 5 5.6% 
     Hispanic/Latino 8 9.0% 
Age at Diagnosis (years) 6.57 4.53 
Age at Evaluation (years) 12.60 4.41 
Years Since Treatment Completion 4.48 3.41 
Diagnosis   
     Pilocytic Astrocytoma  25 28.1% 
     Medulloblastoma 19 21.3% 
     Ependymoma 11 12.4% 
     Low-Grade Glioma 8 9.0% 
     Other 26 29.21% 
Treatment Types†   
     Surgery 75 84.3% 
     Radiation 53 59.6% 
     Chemotherapy 65 73.0% 
Other Diagnoses   
     Posterior Fossa Syndrome 8 9.0% 
     Hydrocephalus 27 30.34% 
     Neurofibromatosis 1 7 7.9% 
Note. †Treatment types are not exclusive, as patients may have 






Table 2. Descriptive Statistics for indicator variables of the entire 
sample. 




Psychosocial Variables   
Internalizing Problems  
(CBCL parent-report) 
54.53 (11.41) 20.5% 
Externalizing Problems  
(CBCL parent-report) 
48.50 (11.33) 11.4% 
Social Problems  
(CBCL parent-report) 
58.54 (9.13) 27.5% 
Internalizing Problems  
(TRF teacher-report) 
50.34 (10.10) 10.9% 
Externalizing Problems  
(TRF teacher-report) 
49.11 (8.81) 6.2% 
Social Problems  
(TRF teacher-report) 
55.85 (7.77) 16.1% 
Neurocognitive Variables   
Total Move Score  
(TOL) 
85.89 (18.01) 33.3%ª 
Total Problem Solving Time 
(TOL) 
85.06 (18.36) 38.9% ª 
Digit Span  
(Wechsler Scale Subtest) 
8.77 (3.15) 33.7%* 
Processing Speed Index 
(Wechsler Scale Index Score) 
86.25 (14.87) 33.3%** 
Note. CBCL = Child Behavior Check List; TRF = Teacher Report 
Form; TOL = Tower of London 
Note. ªCut-off used for TOL scores was the Borderline range (70-
79) or below.*Cut-off used for Digit Span was the Below 
Average range (5-7) or below. **Cut-off used for PSI was the 


















































































































































































































































































































































































































































































































































































































 Figure 1. Psychosocial and neurocognitive domain scores by latent profile. 
Note. To improve visual depiction of scores, average Digit Span scores were multiplied by 10. 
Note. Red lines indicate clinically concerning cut-offs (i.e., CBCL and TRF t-scores > 63; TOL 
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